Fidelity Advisor is trading at 30.70 as of the 28th of December 2024; that is 5.07% down since the beginning of the trading day. The fund's open price was 32.34. Fidelity Advisor has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 1st of July 2024 and ending today, the 28th of December 2024. Click here to learn more.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. More on Fidelity Advisor Biotechnology
Fidelity Advisor Biotechnology [FIJYX] is traded in USA and was established 28th of December 2024. Fidelity Advisor is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. This fund currently has accumulated 1.83 B in assets under management (AUM) with no minimum investment requirementsFidelity Advisor Bio is currently producing year-to-date (YTD) return of 6.89% with the current yeild of 0.01%, while the total return for the last 3 years was 3.49%.
Check Fidelity Advisor Probability Of Bankruptcy
Instrument Allocation
Top Fidelity Advisor Biotechnology Mutual Fund Constituents
Other Information on Investing in Fidelity Mutual Fund
Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.